Preexisting atrial fibrillation and cardiac complications after liver transplantation

Liver Transplantation

Volumn 21, Issue 3, 2015, Pages 314-320

  Bargehr, Johannes ^a,b   Trejo Gutierrez, Jorge F ^a   Patel, Tushar ^a   Rosser, Barry ^a   Aranda Michel, Jaime ^a   Yataco, Maria L ^a   Taner, C Burcin ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; GLYCOSIDE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BILIARY TRACT DISEASE; BODY MASS; BRADYCARDIA; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COLD ISCHEMIA; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOCARDITIS; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GENDER; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART SIZE; HEART VENTRICLE TACHYCARDIA; HEART VOLUME; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIA; KIDNEY DISEASE; KIDNEY FAILURE; LIVER TRANSPLANTATION; LUNG DISEASE; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; MITRAL VALVE REGURGITATION; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; NEUROLOGIC DISEASE; OBESITY; ORGAN DONOR; OVERALL SURVIVAL; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURGICAL INFECTION; SURGICAL MORTALITY; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; VASCULAR DISEASE; ADVERSE EFFECTS; AGED; ATRIAL FIBRILLATION; COMPLICATION; END STAGE LIVER DISEASE; HEART DISEASES; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; ATRIAL FIBRILLATION; END STAGE LIVER DISEASE; FEMALE; FLORIDA; GRAFT SURVIVAL; HEART DISEASES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923544539     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24060     Document Type: Article

References (26)

1. Piccini JP, Hammill BG, Sinner MF, Jensen PN, Hernandez AF, Heckbert SR, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 2012;5:85-93.
2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-473.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-2375.
4. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-1046.
5. Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001;7:811-815.
6. Madhwal S, Atreja A, Albeldawi M, Lopez R, Post A, Costa MA. Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies. Liver Transpl 2012;18:1140-1146.
7. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002;73:901-906.
8. Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, Krom RA. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3:1-9.
9. Timoh T, Protano MA, Wagman G, Bloom M, Vittorio TJ. A perspective on cirrhotic cardiomyopathy. Transplant Proc 2011;43:1649-1653.
10. Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011; 58:223-231.
11. Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al.; for American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease; American Heart Association; American College of Cardiology Foundation. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation 2012;126:617-663.
12. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/ Paisley study. Am J Med 2002;113:359-364.
13. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98:476-484.
14. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al.; for American College of Cardiology Foundation/American Heart Association Task Force. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011;123:e269-367.
15. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011;342:d124.
16. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886-897.
17. Gonwa TA. Hypertension and renal dysfunction in longterm liver transplant recipients. Liver Transpl 2001; 7(suppl 1):S22-S26.
18. Navasa M, Feu F, García-Pagán JC, Jiménez W, Llach J, Rimola A, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993;17:355-360.
19. La Manna G, Boriani G, Capelli I, Marchetti A, Grandinetti V, Spazzoli A, et al. Incidence and predictors of postoperative atrial fibrillation in kidney transplant recipients. Transplantation 2013;96:981-986.
20. Van Wagoner DR
21. Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008;52: 306-313.
22. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115: 135-143.
23. Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004;43:742-748.
24. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al.; for Investigators of the Ischemia Research and Education Foundation and Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-1729.
25. El-Chami MF, Kilgo P, Thourani V, Lattouf OM, Delurgio DB, Guyton RA, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol 2010;55:1370-1376.
26. Bargehr J, Trejo-Gutierrez JF, Rosser BG, Patel T, Yataco ML, Pungpapong S, et al. Liver transplantation in patients with atrial fibrillation. Transplant Proc 2013;45: 2302-2306.